Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (8 total)
-
Creator: NIH
Subject: Treatment & Care
Item Type: Hyperlink
Date Last Updated: 2022-09-26
Description: There is current guidance from the Centers for Disease Control and Prevention, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine detailing the management of pregnant patients with COVID-19. This… -
Creator: NIH
Subject: Infection Control
Item Type: Hyperlink
Date Last Updated: 2020-05-04
Description: This is a phase I, open-label, dose ranging clinical trial in males and non-pregnant females, starting at 18 years of age, inclusive, who are in good health and meet all eligibility criteria. This clinical trial is designed to assess the safety,… -
Creator: NIH
Subject: Treatment & Care
Item Type: Hyperlink
Date Last Updated: 2020-11
Description: These Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines will be updated frequently as… -
Creator: NIH
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2020-02-10
Description: In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia of unknown cause. In a short time, Chinese scientists had shared the genome information of a novel coronavirus (2019-nCoV) from these pneumonia patients… -
Creator: NIH
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2020-02-05
Description: In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia of unknown cause. In a short time, Chinese scientists had shared the genome information of a novel coronavirus (2019-nCoV) from these pneumonia patients… -
Creator: NIH
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2019-08-12
Description: The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20,… -
-
